Skip To The Main Content

PDA New England Chapter: 2023 Dinner Meeting Communications & Azzur Cleanroom Tour

Apr 27, 2023
Devens, MA

  • Chapter

left to register

Program Highlights

Join us for a tour of Azzur Cleanrooms on Demand™ Devens!

We invite you to join us the Azzur Group for a hard hat tour of their Azzur Cleanrooms on Demand™ (COD) facility in Devens, MA! You’ll have an exclusive preview of Azzur’s new ~130,000 sq. ft. facility. A novel approach to early-phase manufacturing with proven outcomes for clients in Burlington and Waltham, COD Devens will offer 30 cleanrooms and associated cGMP services to enable clients to get to manufacturing faster, without the burden of facility ownership and maintenance. Azzur Labs will be co-located in this facility to provide testing services for clients requiring raw material, in-process and final product testing. For more information, visit


The PDA New England Chapter would like to warmly invite you to join us for our 2023 Dinner Meeting Communications & Azzur Cleanroom Tour on 27 April in Devens, MA.

Tour Location:
Azzur Cleanrooms on Demand Devens
45 Jackson Road Devens, MA 01434

When: 4:30PM - 5:30PM
Azzur Cleanrooms


Mary Keville
Mary Keville Consulting, LLC
[email protected]

PDA NE Event Meeting Phase #1, Meeting Topic #1

Topic Title: Quality Management Maturity – A Framework for Improving Quality and Patient Safety and Reducing Costs

Quality management maturity is the state attained when drug manufacturers have consistent, reliable, and robust business processes to achieve quality objectives and promote continual improvement – CDER. A Quality Management Maturity (QMM) Assessment holistically assesses the overall health of a quality management system and provides insight into the prevailing quality culture. Included in this presentation:

  • Recent efforts by the FDA to secure drug supply chains with the piloting of CDERs QMM program.
  • QMM framework: an essential element in charting a course for sustained quality improvement.
  • Case studies
  • How companies can use the QMM framework to improve quality, maximize patient safety, and reduce costs


Jim Morris, BS, MBA, VP of Health Sciences Consulting, NSF

Jim has over 35 years of experience in the pharmaceutical industry. He has held senior level positions in Quality at several companies including Pfizer, J&J and Massachusetts Biologic Labs. He is currently VP of Health Sciences Consulting at NSF (former David Begg Assoc.) where he and the NSF team of consultants provide expert advice in QA/QC, Regulatory CMC and GMP / Regulatory remediation support. NSF Health Sciences is well known for their global GMP training services and Qualified Persons training in Europe. NSF partners with clients on various technical and quality-based projects, spanning traditional drugs, biologics, and combination products. Jim holds a BS in Biological and Physical Sciences from Northwestern and an MBA from Boston University.


Varun Venkatachalam, MS, Principal Consultant, Pharma/Biotech Consulting, NSF

Varun is passionate about Quality Management Maturity and Human Performance in the Lifesciences Manufacturing sector. With over 13 years of experience across Industry (Hospira & Pfizer) and Management Consulting (PwC & EY), Varun is a multifaceted professional with Operational (Strategy and Operational excellence) and Technical (Regulatory, Quality and Manufacturing Systems) expertise. He is currently a Principal consultant in the Pharma/Biotech Consulting team at NSF international, based out of Toronto. Varun is a Biotech Engineer by training and has a MS in Biotechnology from the University of Warwick. He is currently pursuing his Global Executive MBA in Healthcare/Life Sciences at the Rotman School of Management, UofT.

PDA NE Event Meeting Phase #2, meeting topic #2

Topic Title: Accelerating Early Phase Development Through Hybrid Manufacturing

Traditionally, biomanufacturing innovators have two choices for early clinical trial manufacturing: build or broker. With more and more virtual companies on the scene, the capital expense and time needed for building is a non-starter. Today, hybrid options exist that allow a risk-based approach to early phase clinical manufacturing. This presentation will:

  • Explore the different options for biologics development and manufacturing
  • Share results of a 2022 research study outlining the insights and challenges of today’s bio manufacturers
  • Present blended solutions to traditional development and manufacturing options


Ravi Samavedam, Chief Innovation Officer, Azzur Group

Ravi Samavedam, Chief Innovation Officer at Azzur, is a Biochemical Engineer with more than 20 years of experience in the pharmaceutical and biotechnology industries. Prior to his current role, he was President and COO of Azzur Cleanrooms on DemandTM . In 2019, Ravi was a General Manager of Azzur Boston, and has been with the company since 2012. Prior to Azzur, Ravi has been part of the Technical Operations, Quality/Validation departments at Baxter, Amgen, and Shire. Ravi is an expert in phase-appropriate cGMP implementation, Process Validation, Supplier Management, and Technology Transfer. Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.

Agenda Coming Soon

Highlighted Speakers

Jim  Morris, BS, MBA
Jim Morris, BS, MBA
Ravi  Samavedam
Ravi Samavedam
Azzur Group
Varun  Venkatachalam, MS
Varun Venkatachalam, MS

Meeting Location

Devens Common Center


31 Andrews Parkway
Devens, MA


Registration Fees

Regular Price
Registration Type Early Registration
(Sale ends on April 20, 2023)
Late Registration
PDA Member $85 $135
Sponsor $85 $135
Non-Member $115 $135
PDA Student, retired and unemployed members $20 $135


Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information


Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Got a Question? We have answers

Contact Us

PDA Members Save Substantially